Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Ellington, David R.; Richter, Holly E. (2013)
Publisher: Hindawi Publishing Corporation
Journal: Obstetrics and Gynecology International
Languages: English
Types: Article
Subjects: RG1-991, Review Article, Gynecology and obstetrics, Article Subject
Synthetic transvaginal mesh has been employed in the treatment of pelvic organ prolapse for more than a decade. As the use of these devices increased during this period so did adverse event reporting. In 2008, the Food and Drug Administration (FDA) Public Health Notification informed physicians and patients of rising concerns with the use of synthetic transvaginal mesh. Shortly thereafter and in parallel to marked increases in adverse event reporting within the Manufacturer and User Device Experience (MAUDE), the FDA released a Safety Communication regarding urogynecologic surgical mesh use. Following this report and in the wake of increased medical industry product withdrawal, growing medicolegal concerns, patient safety, and clinical practice controversy, many gynecologists and pelvic reconstructive surgeons are left with limited long-term data, clinical guidance, and growing uncertainty regarding the role of synthetic transvaginal mesh use in pelvic organ prolapse. This paper reviews the reported complications of synthetic transvaginal mesh with an evidence-based approach as well as providing suggested guidance for the future role of its use amidst the controversy.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse . 2011
    • Smith, FJ, Holman, CDJ, Moorin, RE, Tsokos, N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstetrics & Gynecology . 2010; 116 (5): 1096-1100
    • Blandon, RE, Bharucha, AE, Melton, LJ. Incidence of pelvic floor repair after hysterectomy: a population-based cohort study. American Journal of Obstetrics & Gynecology . 2007; 197 (6): 664.e1-664.e7
    • Whiteside, JL, Weber, AM, Meyn, LA, Walters, MD. Risk factors for prolapse recurrence after vaginal repair. American Journal of Obstetrics & Gynecology . 2004; 191 (5): 1533-1538
    • Sung, VW, Rogers, RG, Schaffer, JI. Graft use in transvaginal pelvic organ prolapse repair: a systematic review. Obstetrics & Gynecology . 2008; 112 (5): 1131-1142
    • Ellington, DR, Richter, HE. Indications, contraindications, and complications of mesh in surgical treatment of pelvic organ prolapse. Clinical Obstetrics & Gynecology . 2013; 56 (2): 276-288
    • Surgical mesh for the treatment of women with pelvic organ prolapse and stress urinary incontinence.
    • Ignjatovic, I, Stosic, D. Retrovesical haematoma after anterior Prolift procedure for cystocele correction. International Urogynecology Journal . 2007; 18 (12): 1495-1497
    • Yamada, BS, Govier, FE, Stefanovic, KB, Kobashi, KC. Vesicovaginal fistula and mesh erosion after perigee (transobturator polypropylene mesh anterior repair). Urology . 2006; 68 (5): 1121.e5-1121.e7
    • Brill, AI. The hoopla over mesh: what it means for practice. Obstetrics & Gynecology News . 2012: 14-15
    • Haylen, BT, Freeman, RM, Swift, SE. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) & grafts in female pelvic floor surgery. International Urogynecology Journal . 2011; 22 (1): 3-15
    • Nguyen, JN, Jakus-Waldman, SM, Walter, AJ, White, T, Menefee, SA. Perioperative complications and reoperations after incontinence and prolapse surgeries using prosthetic implants. Obstetrics & Gynecology . 2012; 119 (3): 539-546
    • Abed, H, Rahn, DD, Lowenstein, L, Balk, EM, Clemons, JL, Rogers, RG. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. International Urogynecology Journal . 2011; 22 (7): 789-798
    • Rardin, CR, Washington, BB. New considerations in the use of vaginal mesh for prolapse repair. Journal of Minimally Invasive Gynecology . 2009; 16 (3): 360-364
    • Brubaker, L, Glazener, C, Jacquentin, B. Surgery for pelvic organ prolapse. : 1273-1320
    • Weber, AM, Walters, MD, Piedmonte, MR. Sexual function and vaginal anatomy in women before and after surgery for pelvic organ prolapse and urinary incontinence. American Journal of Obstetrics & Gynecology . 2000; 182 (6): 1610-1615
    • Milani, R, Salvatore, S, Soligo, M, Pifarotti, P, Meschia, M, Cortese, M. Functional and anatomical outcome of anterior and posterior vaginal prolapse repair with prolene mesh. BJOG . 2005; 112 (1): 107-111
    • Nieminen, K, Hiltunen, R, Heiskanen, E. Symptom resolution and sexual function after anterior vaginal wall repair with or without polypropylene mesh. International Urogynecology Journal . 2008; 19 (12): 1611-1616
    • Sentilhes, L, Berthier, A, Sergent, F, Verspyck, E, Descamps, P, Marpeau, L. Sexual function in women before and after transvaginal mesh repair for pelvic organ prolapse. International Urogynecology Journal . 2008; 19 (6): 763-772
    • Davila, GW, Baessler, K, Cosson, M, Cardozo, L. Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. International Urogynecology Journal . 2012; 23 (supplement 1): S7-S14
    • Firoozi, F, Ingber, MS, Moore, CK, Vasavada, SP, Rackley, RR, Goldman, HB. Purely transvaginal/perineal management of complications from commercial prolapse kits using a new prostheses/grafts complication classification system. Journal of Urology . 2012; 187 (5): 1674-1679
    • Feiner, B, Maher, C. Vaginal mesh contraction: definition, clinical presentation, and management. Obstetrics & Gynecology . 2010; 115 (2): 325-330
    • Moore, RD, Miklos, JR. Vaginal mesh kits for pelvic organ prolapse, friend or foe: a comprehensive review. TheScientificWorldJOURNAL . 2009; 9: 163-189
    • Maher, C, Feiner, B, Baessler, K, Glazener, CM. Surgical management of pelvic organ prolapse in women. Cochrane Database of Systematic Reviews . 2010 (4)
    • Altman, D, Väyrynen, T, Engh, ME, Axelsen, S, Falconer, C. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. The New England Journal of Medicine . 2011; 364 (19): 1826-1836
    • Committee opinion no. 513: vaginal placement of synthetic mesh for pelvic organ prolapse. Obstetrics & Gynecology . 2011; 118 (6): 1459-1464
    • Jelovsek, JE, Barber, MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. American Journal of Obstetrics & Gynecology . 2006; 194 (5): 1455-1461
    • Arya, LA, Novi, JM, Shaunik, A, Morgan, MA, Bradley, CS. Pelvic organ prolapse, constipation, and dietary fiber intake in women: a case-control study. American Journal of Obstetrics & Gynecology . 2005; 192 (5): 1687-1691
    • Araco, F, Gravante, G, Sorge, R. The influence of BMI, smoking, and age on vaginal erosions after synthetic mesh repair of pelvic organ prolapses. A multicenter study. Acta Obstetricia et Gynecologica Scandinavica . 2009; 88 (7): 772-780
    • Chen, CCG, Collins, SA, Rodgers, AK, Paraiso, MFR, Walters, MD, Barber, MD. Perioperative complications in obese women vs normal-weight women who undergo vaginal surgery. American Journal of Obstetrics & Gynecology . 2007; 197 (1): 98.e1-98.e8
    • Collinet, P, Belot, F, Debodinance, P, Ha Duc, E, Lucot, J-P, Cosson, M. Transvaginal mesh technique for pelvic organ prolapse repair: mesh exposure management and risk factors. International Urogynecology Journal . 2006; 17 (4): 315-320
    • Lowman, JK, Woodman, PJ, Nosti, PA, Bump, RC, Terry, CL, Hale, DS. Tobacco use is a risk factor for mesh erosion after abdominal sacral colpoperineopexy. American Journal of Obstetrics & Gynecology . 2008; 198 (5): 561.e1-561.e4
    • Caquant, F, Collinet, P, Debodinance, P. Safety of trans vaginal mesh procedure: retrospective study of 684 patients. Journal of Obstetrics and Gynaecology Research . 2008; 34 (4): 449-456
    • Wang, AC, Lee, L-Y, Lin, C-T, Chen, J-R. A histologic and immunohistochemical analysis of defective vaginal healing after continence taping procedures: a prospective case-controlled pilot study. American Journal of Obstetrics & Gynecology . 2004; 191 (6): 1868-1874
    • FDA safety communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. July 2011
    • Surgical placement of mesh to repair pelvic organ prolapse imposes risks. July 2011
    • FDA safety communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. July 2011
    • Position statement on the use of vaginal mesh in pelvic surgery. August 2011
    • FDA safety communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. July 2011
  • No related research data.
  • No similar publications.

Share - Bookmark

Funded by projects

  • NIH | Mid Career Award in Patient...

Cite this article